E
ZyVersa Therapeutics, Inc. ZVSA
$0.7899 -$0.0111-1.39%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 7.71M 8.11M 9.99M 11.21M 13.19M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 9.63M 10.26M 12.66M 14.42M 17.83M
Operating Income -9.63M -10.26M -12.66M -14.42M -17.83M
Income Before Tax -21.92M -22.42M -105.99M -107.75M -99.24M
Income Tax Expenses -586.40K -586.90K -8.41M -9.46M -9.60M
Earnings from Continuing Operations -21.33 -21.83 -97.58 -98.30 -89.64
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -21.33M -21.83M -97.58M -98.30M -89.64M
EBIT -9.63M -10.26M -12.66M -14.42M -17.83M
EBITDA -9.62M -10.25M -12.64M -14.41M -17.82M
EPS Basic -69.90 -97.65 -1.79K -1.92K -1.86K
Normalized Basic EPS -11.38 -28.51 -89.55 -196.73 -191.80
EPS Diluted -69.90 -97.65 -1.79K -1.92K -1.86K
Normalized Diluted EPS -11.38 -28.51 -89.55 -196.73 -191.80
Average Basic Shares Outstanding 2.67M 1.78M 995.60K 398.10K 91.71M
Average Diluted Shares Outstanding 2.67M 1.78M 995.60K 398.10K 91.71M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings